Dongguan, China

Shuhui Chen

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Guangdong Raynovent Biotech Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuhui Chen. Retrieved from https://idiyas.com/inventor/shuhui-chen-ppi908ys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Dongguan, CN (2020)
  • Pudong New Area, CN (2020)

Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shuhui Chen: Innovator in Pharmaceutical Composition

Introduction

Shuhui Chen is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds.

Latest Patents

Shuhui Chen holds two patents that showcase his expertise. The first patent is for a tyrosine kinase inhibitor and a pharmaceutical composition comprising the same. This invention relates to a specific structure of the tyrosine kinase inhibitor, which is crucial for therapeutic applications. The second patent involves a series of hydroxyl purine compounds and their use as PDE2 or TNFα inhibitors. These compounds are particularly valuable in the treatment of various diseases.

Career Highlights

Shuhui Chen is associated with Guangdong Raynovent Biotech Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector.

Collaborations

Some of his coworkers include Chaofeng Long and Xiaoxin Chen, who contribute to the innovative environment at their company.

Conclusion

Shuhui Chen's contributions to pharmaceutical innovations highlight his role as a leading inventor in the industry. His patents reflect a commitment to advancing medical science through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…